Maximizing Safety And Efficacy In Hematopoietic Stem Cell Gene Therapy

As hematopoietic stem cell gene therapies advance toward wider clinical use, manufacturing processes must support both scientific rigor and practical scalability. Automated, closed-system workflows offer a path to more consistent CD34+ stem cell engineering by reducing manual variability and supporting efficient lentiviral transduction. In comparative evaluations, selected transduction enhancers improved gene transfer efficiency while maintaining cell recovery, viability, and key functional characteristics. Additional measures, including colony-forming potential and vector copy number, provide a fuller picture of how genetic modification affects overall stem cell quality.

Access the full poster to learn about the value of automation in helping standardize production, strengthen process control, and support safer, more scalable manufacturing strategies.